RU93058676A - ORAL TREATMENT OF HELICOBACTERIAL INFECTION - Google Patents
ORAL TREATMENT OF HELICOBACTERIAL INFECTIONInfo
- Publication number
- RU93058676A RU93058676A RU93058676/14A RU93058676A RU93058676A RU 93058676 A RU93058676 A RU 93058676A RU 93058676/14 A RU93058676/14 A RU 93058676/14A RU 93058676 A RU93058676 A RU 93058676A RU 93058676 A RU93058676 A RU 93058676A
- Authority
- RU
- Russia
- Prior art keywords
- infection
- helicobacter
- host
- helicobacterial
- treatment
- Prior art date
Links
- 201000009910 diseases by infectious agent Diseases 0.000 title 1
- 206010019375 Helicobacter infection Diseases 0.000 claims 4
- 230000001681 protective Effects 0.000 claims 3
- 241000589989 Helicobacter Species 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000038129 antigens Human genes 0.000 claims 2
- 108091007172 antigens Proteins 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 229960005486 vaccines Drugs 0.000 claims 2
- 206010056663 Gastric infection Diseases 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86828692A | 1992-04-13 | 1992-04-13 | |
US868286 | 1992-04-13 | ||
PCT/US1993/003409 WO1993020843A1 (en) | 1992-04-13 | 1993-04-09 | Oral treatment of helicobacter infection |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93058676A true RU93058676A (en) | 1997-02-10 |
RU2107513C1 RU2107513C1 (en) | 1998-03-27 |
Family
ID=25351374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93058676A RU2107513C1 (en) | 1992-04-13 | 1993-04-09 | Oral treatment of helicobacter infection |
Country Status (17)
Country | Link |
---|---|
US (1) | US5538729A (en) |
EP (1) | EP0590138A4 (en) |
JP (1) | JPH07500845A (en) |
BG (1) | BG61935B1 (en) |
BR (1) | BR9305482A (en) |
CA (1) | CA2111189A1 (en) |
CZ (1) | CZ273093A3 (en) |
FI (1) | FI935591A (en) |
HU (1) | HU214699B (en) |
MX (1) | MX9301706A (en) |
NO (1) | NO934547D0 (en) |
NZ (1) | NZ251849A (en) |
OA (1) | OA10213A (en) |
RU (1) | RU2107513C1 (en) |
SG (1) | SG52556A1 (en) |
SK (1) | SK281238B6 (en) |
WO (1) | WO1993020843A1 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2682122B1 (en) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | NEW GENES OF HELICOBACTER PYLORI. THEIR USE FOR THE PREPARATION OF RECOMBINANT STRAINS OF H. PYLORI. |
ATE273021T1 (en) * | 1992-02-26 | 2004-08-15 | Univ Vanderbilt | PURIFIED VACUOLIZING TOXIN FROM HELICOBACTER PYLORI AND METHODS OF USE THEREOF |
US7141244B1 (en) * | 1992-03-02 | 2006-11-28 | Chiron Srl | Helicobacter pylori proteins useful for vaccines and diagnostics |
MX9301706A (en) * | 1992-04-13 | 1994-05-31 | Oravax Inc | VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION. |
US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
US5843460A (en) * | 1993-05-19 | 1998-12-01 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
WO1995014093A1 (en) | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
KR100333113B1 (en) * | 1993-07-27 | 2002-11-27 | 시에스엘 리미티드 | Treatment of h. pylori associated gastroduodenal disease |
US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
AUPM399594A0 (en) | 1994-02-21 | 1994-03-17 | Csl Limited | Antigenic preparation for treatment or prevention of helicobacter infection |
US5780040A (en) * | 1994-06-08 | 1998-07-14 | Tufts University School Of Medicine Hospital, Inc. | Helicobacter pylori nickel binding protein |
AUPM612494A0 (en) | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
AU702878B2 (en) * | 1994-06-08 | 1999-03-11 | Csl Limited | Treatment and prevention of helicobacter infection |
JPH10502365A (en) * | 1994-07-01 | 1998-03-03 | リカン・リミテッド | Helicobacter proteins and vaccines |
SG90030A1 (en) * | 1994-10-05 | 2002-07-23 | Microcarb Inc | Methods for producing enhanced antigenic helocobacter sp. and vaccines comprising same |
US5897475A (en) * | 1994-10-05 | 1999-04-27 | Antex Biologics, Inc. | Vaccines comprising enhanced antigenic helicobacter spp. |
FR2732605B1 (en) * | 1995-04-07 | 1997-05-16 | Pasteur Merieux Serums Vacc | COMPOSITION FOR INDUCING MUCOSAL IMMUNE RESPONSE |
AR003125A1 (en) * | 1995-06-01 | 1998-07-08 | Astra Ab | BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE |
EP0797585A1 (en) * | 1995-10-09 | 1997-10-01 | Pasteur Merieux Serums Et Vaccins | Helicobacter lactoferrin receptor |
GB2307987A (en) * | 1995-12-06 | 1997-06-11 | Univ Manchester | Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto |
EP0876476A4 (en) * | 1995-12-19 | 2001-04-18 | Univ Iowa State Res Found Inc | Heterophil-adapted poultry vaccine |
GB2324093A (en) * | 1996-01-04 | 1998-10-14 | Rican Limited | Helicobacter pylori bacterioferritin |
NZ333250A (en) * | 1996-06-10 | 2000-05-26 | Thomas Boren | Helicobacter pylori blood group antigen binding adhesion protein |
WO1998043479A1 (en) * | 1997-04-01 | 1998-10-08 | Merieux Oravax | 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
US20020026035A1 (en) * | 1997-04-01 | 2002-02-28 | Harold Kleanthous | Helicobacter ghpo 1360 and ghpo 750 polypeptides and corresponding polynucleotide molecules |
US20030124141A1 (en) * | 1997-04-01 | 2003-07-03 | Rainer Haas | Helicobacter polypeptides and corresponding polynucleotide molecules |
JP3430853B2 (en) | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | Preventive and therapeutic agents for gastritis, gastric ulcer and duodenal ulcer |
SE9702240D0 (en) * | 1997-06-12 | 1997-06-12 | Astra Ab | Vaccine compositions III |
KR100509817B1 (en) * | 1997-06-27 | 2005-12-16 | 씨제이 주식회사 | Oral vaccine for prevention of vibrio vulnificus infection |
US20030158396A1 (en) * | 1997-07-29 | 2003-08-21 | Harold Kleanthous | Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome |
US6599509B2 (en) * | 1997-09-02 | 2003-07-29 | Massachusetts Institute Of Technology | Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
US5985631A (en) * | 1997-09-12 | 1999-11-16 | Oravax-Merieux Co. | Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease |
SE9801288D0 (en) | 1998-04-14 | 1998-04-14 | Astra Ab | Vaccine delivery system and method of production |
US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
CA2335487A1 (en) | 1998-06-19 | 1999-12-23 | Merieux Oravax | Lt and ct in parenteral immunization methods against helicobacter infection |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
JP2005506322A (en) * | 2001-08-31 | 2005-03-03 | カイロン ソチエタ ア レスポンサビリタ リミタータ | Helicobacter pylori vaccination |
ATE516817T1 (en) * | 2005-06-16 | 2011-08-15 | Univ Gent | VACCINES FOR IMMUNIZATION AGAINST HELICOBACTER |
US7790143B2 (en) * | 2005-06-16 | 2010-09-07 | Universiteit Gent | Vaccines for immunization against helicobacter |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5417986A (en) * | 1984-03-16 | 1995-05-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
US5268276A (en) * | 1988-09-16 | 1993-12-07 | Jan Holmgren | Recombinant systems for expression of cholera B-sub-unit with the aid of foreign promoters and/or leader peptides |
FR2637612B1 (en) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | NUCLEOTIDE SEQUENCES ENCODING A PROTEIN WITH UREASIC ACTIVITY |
DE4139840B4 (en) * | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen preparation for the detection of H. pylori |
EP0582672A4 (en) | 1991-04-26 | 1994-06-29 | Emanuel Calenoff | Methods to detect and treat diseases caused by bacterial allergens |
FR2682122B1 (en) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | NEW GENES OF HELICOBACTER PYLORI. THEIR USE FOR THE PREPARATION OF RECOMBINANT STRAINS OF H. PYLORI. |
ATE273021T1 (en) * | 1992-02-26 | 2004-08-15 | Univ Vanderbilt | PURIFIED VACUOLIZING TOXIN FROM HELICOBACTER PYLORI AND METHODS OF USE THEREOF |
JP3368902B2 (en) * | 1992-03-02 | 2003-01-20 | カイロン エセ.ピー.アー. | Helicobacter pylori proteins useful for vaccines and diagnostics |
MX9301706A (en) * | 1992-04-13 | 1994-05-31 | Oravax Inc | VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION. |
-
1993
- 1993-03-26 MX MX9301706A patent/MX9301706A/en unknown
- 1993-04-09 CA CA002111189A patent/CA2111189A1/en not_active Abandoned
- 1993-04-09 SK SK1412-93A patent/SK281238B6/en unknown
- 1993-04-09 CZ CZ932730A patent/CZ273093A3/en unknown
- 1993-04-09 RU RU93058676A patent/RU2107513C1/en active
- 1993-04-09 WO PCT/US1993/003409 patent/WO1993020843A1/en not_active Application Discontinuation
- 1993-04-09 SG SG1996005966A patent/SG52556A1/en unknown
- 1993-04-09 EP EP93909307A patent/EP0590138A4/en not_active Withdrawn
- 1993-04-09 JP JP5518527A patent/JPH07500845A/en not_active Ceased
- 1993-04-09 HU HU9303561A patent/HU214699B/en not_active IP Right Cessation
- 1993-04-09 BR BR9305482A patent/BR9305482A/en not_active Application Discontinuation
- 1993-04-09 NZ NZ251849A patent/NZ251849A/en unknown
- 1993-12-10 NO NO934547D patent/NO934547D0/en unknown
- 1993-12-13 FI FI935591A patent/FI935591A/en unknown
- 1993-12-13 BG BG98294A patent/BG61935B1/en unknown
- 1993-12-13 OA OA60449A patent/OA10213A/en unknown
-
1994
- 1994-08-22 US US08/293,565 patent/US5538729A/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93058676A (en) | ORAL TREATMENT OF HELICOBACTERIAL INFECTION | |
NO963508L (en) | Urease-based vaccine and treatment of Helicobacter infection | |
PL304419A1 (en) | Urease based vaccine against heliobacter infections | |
RU94037239A (en) | METHOD FOR CALLING PROTECTIVE IMMUNE RESPONSE TO HELIOBACTER INFECTION, VACCINE BASED ON UREASIS AGAINST HELIOBACTER INFECTION, METHOD OF PROTECTING AGAINST HELIOBACTER INFECTION, METHOD OF ASSESSMENT ASSESSMENT | |
KR970703164A (en) | Treatment and Prevention of Helicobacter Infection (TREATMENT AND PREVENTION OF HELICOBACTER INFECTION) | |
CA2117490A1 (en) | Purified vacuolating toxin from helicobacter pylori and methods to use same | |
DK0539522T3 (en) | Improved immunotherapeutic approach for the prevention or treatment of viral disease of the respiratory tract | |
NZ314585A (en) | Method of treating H. Pylori associated gastroduodenal disease | |
HUP9801266A2 (en) | Multimeric, recombinant urease vaccine | |
NZ331557A (en) | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis | |
DE69527986D1 (en) | ANTIGEN MEDICINE FOR TREATMENT OR PREVENTION | |
ATE285791T1 (en) | VACCINE CONTAINING ACEMANNAN AS AN ADJUVANT | |
SE9604322D0 (en) | Bacterial antigens and vaccine compositions II | |
CA2128247A1 (en) | Vaccines based on streptokinase | |
HUP0003164A2 (en) | Vaccine compositions comprising the helicobacter pylori flge polypeptide | |
EP0328390A3 (en) | Peptide treatment of refractory infectious diseases | |
ATE206138T1 (en) | HELICOBACTER PYLORI ANTIGEN | |
NO934547L (en) | Oral treatment of Helicobacter infection | |
RU98123839A (en) | HELICOBACTER PYLORI VACCINE COMPOSITION CONTAINING FLAGELLIN POLYPEPTIDE | |
SU1739559A1 (en) | TREATMENT OF APHTAE EPIZOOTICAE VIRUS TYPE O, USED TO MAKE DIAGNOSTIC SERIES AND ANTIGEN DRUGS | |
RU96123906A (en) | METHOD AND VACCINE FOR PREVENTION AND TREATMENT OF IMMUNO DEFICIENCIES, FOR EXAMPLE CANCER |